Clinical Program to Treat Individuals With Tecovirimat (ST-246) After Exposure to Orthopox Viruses

Trial Profile

Clinical Program to Treat Individuals With Tecovirimat (ST-246) After Exposure to Orthopox Viruses

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Tecovirimat (Primary)
  • Indications Monkeypox; Orthopoxvirus infections; Vaccinia
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 28 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top